|

Multiple Sclerosis Clinical Trials in Arizona

13 recruiting studies across 3 cities

Browse by City

Mesa
10 trials
Phoenix
10 trials
Tucson
4 trials

All Trials in Arizona

Phase
Trial Phase Dist.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—<1 mi
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 3<1 mi
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisPhase 3<1 mi
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyPhase 1/2<1 mi
Study of COYA 302 for the Treatment of ALSPhase 2/3<1 mi
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 3<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 23 mi
A Study of AZD0120 in Autoimmune DiseasesPhase 13 mi
An Open-label Study of AZD0120 in Adults With Multiple SclerosisPhase 13 mi
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityPhase 28 mi
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSPhase 28 mi
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisPhase 38 mi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 38 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.